
AtriCure, Inc.: shareholders and insiders
Price
$54.11
November 19, 2026Market cap $2.7B
What Ploutos Investor adds for AtriCure
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 10, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$5.1M
9 people
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan28%
- The rest72%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $4.4M by 9 people
- 2025: no buys, sold $676.4K by 3 people
- 2026: no buys, sold $4.4M by 9 people
- Nov 6, 2026B Kristine JohnsonDirectorKind
- Nov 4, 2026Salvatore PriviteraChief Technical OfficerKind10b5-1
- Sep 23, 2026Salvatore PriviteraChief Technical OfficerKind10b5-1
- Sep 11, 2026Regina E GrovesDirectorKind
- Sep 8, 2026Salvatore PriviteraChief Technical OfficerKind10b5-1
- Sep 2, 2026Salvatore PriviteraChief Technical OfficerKind10b5-1
- Aug 24, 2026Karl S. DahlquistChief Legal OfficerKind
- Aug 5, 2026Karen PrangeDirectorKind
- Aug 5, 2026Maggie YuenDirectorKind
- Jul 30, 2026Michael H CarrelPresident, CEO, & DirectorKind
- Jul 30, 2026Michael H CarrelPresident, CEO, & DirectorKind
- Jul 29, 2026Justin J NozneskyChief Mktg & Strategy OfficerKind
- Jul 28, 2026Vinayak DoraiswamyChief Scientific OfficerKind
- Jul 28, 2026Sven WehrweinDirectorKind
- Jul 28, 2026Sven WehrweinDirectorKind
- Jun 30, 2026Michael H CarrelPresident, CEO, & DirectorKind
- Jun 30, 2026Vinayak DoraiswamyChief Scientific OfficerKind
- Jun 30, 2026Karl S. DahlquistChief Legal OfficerKind
- Jun 30, 2026Douglas J SeithChief Operating OfficerKind
- Jun 30, 2026Salvatore PriviteraChief Technical OfficerKind
- May 20, 2026Karen PrangeKind
- May 15, 2026Vinayak DoraiswamyChief Scientific OfficerKind
- Mar 12, 2026Vinayak DoraiswamyChief Scientific OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | B Kristine JohnsonDirector | 2,452 | $58.48 | $143.4K | Form 4 | |
| Nov 4, 2026 | Salvatore PriviteraChief Technical Officer | 10b5-1 | 8,404 | $65.00 | $546.3K | Form 4 |
| Sep 23, 2026 | Salvatore PriviteraChief Technical Officer | 10b5-1 | 4,519 | $60.00 | $271.1K | Form 4 |
| Sep 11, 2026 | Regina E GrovesDirector | 5,313 | $54.22 | $288.1K | Form 4 | |
| Sep 8, 2026 | Salvatore PriviteraChief Technical Officer | 10b5-1 | 3,657 | $55.00 | $201.1K | Form 4 |
| Sep 2, 2026 | Salvatore PriviteraChief Technical Officer | 10b5-1 | 7,763 | $52.50 | $407.6K | Form 4 |
| Aug 24, 2026 | Karl S. DahlquistChief Legal Officer | 9,370 | $48.89 | $458.1K | Form 4 | |
| Aug 5, 2026 | Karen PrangeDirector | 3,564 | $38.80 | $138.3K | Form 4 | |
| Aug 5, 2026 | Maggie YuenDirector | 3,500 | $38.42 | $134.5K | Form 4 | |
| Jul 30, 2026 | Michael H CarrelPresident, CEO, & Director | 700 | – | – | Form 4 | |
| Jul 30, 2026 | Michael H CarrelPresident, CEO, & Director | 4,000 | – | – | Form 4 | |
| Jul 29, 2026 | Justin J NozneskyChief Mktg & Strategy Officer | 6,182 | $38.80 | $239.9K | Form 4 | |
| Jul 28, 2026 | Vinayak DoraiswamyChief Scientific Officer | 6,000 | $38.88 | $233.3K | Form 4 | |
| Jul 28, 2026 | Sven WehrweinDirector | 25.0K | $19.95 | $498.8K | Form 4 | |
| Jul 28, 2026 | Sven WehrweinDirector | 25.0K | $37.84 | $946.0K | Form 4 | |
| Jun 30, 2026 | Michael H CarrelPresident, CEO, & Director | 636 | $23.78 | $15.1K | Form 4 | |
| Jun 30, 2026 | Vinayak DoraiswamyChief Scientific Officer | 636 | $23.78 | $15.1K | Form 4 | |
| Jun 30, 2026 | Karl S. DahlquistChief Legal Officer | 636 | $23.78 | $15.1K | Form 4 | |
| Jun 30, 2026 | Douglas J SeithChief Operating Officer | 527 | $23.78 | $12.5K | Form 4 | |
| Jun 30, 2026 | Salvatore PriviteraChief Technical Officer | 636 | $23.78 | $15.1K | Form 4 | |
| May 20, 2026 | Karen Prange | 3,000 | $28.65 | $86.0K | Form 4 | |
| May 15, 2026 | Vinayak DoraiswamyChief Scientific Officer | 5,000 | $28.13 | $140.7K | Form 4 | |
| Mar 12, 2026 | Vinayak DoraiswamyChief Scientific Officer | 5,000 | $29.83 | $149.2K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ATRC's officers and directors from 2005 up to November 19, 2025, 21 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 16 more, back to 2005
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class15.4%
- Vanguard Portfolio ManagementShare of class7.22%
- Wellington Management Group LLPwith 3 more personsShare of class6.80%
- Hood River Capital Management LLCShare of class6.23%
- AllianceBernstein L.P.Share of class5.50%
- Vanguard Capital ManagementShare of class5.08%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.4% | 7.84M | Oct 5, 20262 filings since Oct 17, 2025 | 13G/A | |
| Vanguard Portfolio Management | 7.22% | 3.68M | Oct 30, 20262 filings since Apr 28, 2026 | 13G/A | |
| Wellington Management Group LLPwith 3 more persons | 6.80% | 3.38M | May 15, 20262 filings since Aug 12, 2025 | 13G/A | |
| Hood River Capital Management LLC | 6.23% | 3.10M | Feb 17, 20262 filings since Feb 14, 2025 | 13G/A | |
| AllianceBernstein L.P. | 5.50% | 2.77M | Aug 14, 2026 | 13G/A | |
| Vanguard Capital Management | 5.08% | 2.53M | Apr 29, 2026 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter+220%
- Renaissance TechnologiesIn the quarter+37%
- Bridgewater (Dalio)In the quarter-45%
- Point72 (Cohen)In the quarter-80%
- D.E. ShawIn the quarter+69%
- AQR CapitalIn the quarter-11%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 567.5K | +220% | $32M | 0.02% |
| Renaissance Technologies | 321.0K | +37% | $18M | 0.02% |
| Bridgewater (Dalio) | 42.2K | -45% | $2.4M | 0.01% |
| Point72 (Cohen) | 117.9K | -80% | $6.6M | 0.01% |
| D.E. Shaw | 325.7K | +69% | $18M | 0.01% |
| AQR Capital | 483.0K | -11% | $27M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 9.81% of its shares outstanding were held short, +1.4% since the report before.
- Shares held short
- 4.89M
- 9.81%
- Since the report before4.82M on Sep 30, 2026
- +1.4%
- 5.2
- 937.5K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 63%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.37M
- Nov 15, 2023: Shares held short 1.62M
- Nov 30, 2023: Shares held short 1.96M
- Dec 15, 2023: Shares held short 1.94M
- Dec 29, 2023: Shares held short 1.72M
- Jan 12, 2024: Shares held short 1.93M
- Jan 31, 2024: Shares held short 2.22M
- Feb 15, 2024: Shares held short 2.34M
- Feb 29, 2024: Shares held short 2.37M
- Mar 15, 2024: Shares held short 2.97M
- Mar 28, 2024: Shares held short 3.25M
- Apr 15, 2024: Shares held short 3.20M
- Apr 30, 2024: Shares held short 2.98M
- May 15, 2024: Shares held short 3.09M
- May 31, 2024: Shares held short 3.53M
- Jun 14, 2024: Shares held short 3.30M
- Jun 28, 2024: Shares held short 3.69M
- Jul 15, 2024: Shares held short 3.63M
- Jul 31, 2024: Shares held short 3.11M
- Aug 15, 2024: Shares held short 3.64M
- Aug 30, 2024: Shares held short 3.58M
- Sep 13, 2024: Shares held short 3.55M
- Sep 30, 2024: Shares held short 3.59M
- Oct 15, 2024: Shares held short 3.29M
- Oct 31, 2024: Shares held short 2.25M
- Nov 15, 2024: Shares held short 1.67M
- Nov 29, 2024: Shares held short 1.69M
- Dec 13, 2024: Shares held short 1.60M
- Dec 31, 2024: Shares held short 1.62M
- Jan 15, 2025: Shares held short 1.47M
- Jan 31, 2025: Shares held short 1.17M
- Feb 14, 2025: Shares held short 1.28M
- Feb 28, 2025: Shares held short 1.42M
- Mar 14, 2025: Shares held short 1.70M
- Mar 31, 2025: Shares held short 1.34M
- Apr 15, 2025: Shares held short 1.34M
- Apr 30, 2025: Shares held short 1.53M
- May 15, 2025: Shares held short 1.56M
- May 30, 2025: Shares held short 1.83M
- Jun 13, 2025: Shares held short 1.56M
- Jun 30, 2025: Shares held short 1.55M
- Jul 15, 2025: Shares held short 1.52M
- Jul 31, 2025: Shares held short 2.22M
- Aug 15, 2025: Shares held short 1.95M
- Aug 29, 2025: Shares held short 2.08M
- Sep 15, 2025: Shares held short 2.06M
- Sep 30, 2025: Shares held short 2.21M
- Oct 15, 2025: Shares held short 2.05M
- Oct 31, 2025: Shares held short 2.30M
- Nov 14, 2025: Shares held short 2.55M
- Nov 28, 2025: Shares held short 2.30M
- Dec 15, 2025: Shares held short 2.50M
- Dec 31, 2025: Shares held short 2.37M
- Jan 15, 2026: Shares held short 2.51M
- Jan 30, 2026: Shares held short 2.51M
- Feb 13, 2026: Shares held short 3.45M
- Feb 27, 2026: Shares held short 3.15M
- Mar 13, 2026: Shares held short 3.41M
- Mar 31, 2026: Shares held short 3.54M
- Apr 15, 2026: Shares held short 3.61M
- Apr 30, 2026: Shares held short 3.86M
- May 15, 2026: Shares held short 4.43M
- May 29, 2026: Shares held short 3.40M
- Jun 15, 2026: Shares held short 3.44M
- Jun 30, 2026: Shares held short 4.45M
- Jul 15, 2026: Shares held short 4.86M
- Jul 31, 2026: Shares held short 3.86M
- Aug 14, 2026: Shares held short 3.92M
- Aug 31, 2026: Shares held short 4.14M
- Sep 15, 2026: Shares held short 4.28M
- Sep 30, 2026: Shares held short 4.82M
- Oct 15, 2026: Shares held short 4.89M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading57.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 57.5% of the shares in the reported trades were short sales, against 64.9% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 57.5%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 64.9%
- Change
- -7.4 pts
- Short sales a dayon average, of 322.0K shares
- 185.1K
- More than atof 3,666 US-listed companies, same days
- 76%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 61.4%
- Oct 14, 2026: Short sales 61.2%
- Oct 15, 2026: Short sales 58.6%
- Oct 16, 2026: Short sales 75.1%
- Oct 19, 2026: Short sales 67.1%
- Oct 20, 2026: Short sales 65.6%
- Oct 21, 2026: Short sales 61.2%
- Oct 22, 2026: Short sales 68.7%
- Oct 23, 2026: Short sales 65.4%
- Oct 26, 2026: Short sales 69.1%
- Oct 27, 2026: Short sales 74.4%
- Oct 28, 2026: Short sales 62.5%
- Oct 29, 2026: Short sales 73.8%
- Oct 30, 2026: Short sales 53.7%
- Nov 2, 2026: Short sales 43.7%
- Nov 3, 2026: Short sales 39.8%
- Nov 4, 2026: Short sales 79.2%
- Nov 5, 2026: Short sales 66.2%
- Nov 6, 2026: Short sales 60.8%
- Nov 9, 2026: Short sales 55.2%
- Nov 10, 2026: Short sales 43.8%
- Nov 11, 2026: Short sales 57.7%
- Nov 12, 2026: Short sales 68.9%
- Nov 13, 2026: Short sales 79.2%
- Nov 16, 2026: Short sales 63.9%
- Nov 17, 2026: Short sales 58%
- Nov 18, 2026: Short sales 61%
- Nov 19, 2026: Short sales 54.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Michael H CarrelPresident, CEO, & DirectorDirectly792.7K
- Douglas J SeithChief Operating OfficerDirectly229.9K
- Salvatore PriviteraChief Technical OfficerDirectly134.3K
- Justin J NozneskyChief Mktg & Strategy OfficerDirectly100.2K
- Karl S. DahlquistChief Legal OfficerDirectly87.3K
- Vinayak DoraiswamyChief Scientific OfficerDirectly86.5K
- B Kristine JohnsonDirectorDirectly53.5K
- Sven WehrweinDirectorDirectly40.5K
- Regina E GrovesDirectorDirectly34.5K
- Karen PrangeDirectorDirectly22.8K
- Maggie YuenDirectorDirectly14.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Michael H CarrelPresident, CEO, & Director | 792.7K | – | Jul 30, 2026 | Form 4 |
| Douglas J SeithChief Operating Officer | 229.9K | – | Jun 30, 2026 | Form 4 |
| Salvatore PriviteraChief Technical Officer | 134.3K | – | Nov 4, 2026 | Form 4 |
| Justin J NozneskyChief Mktg & Strategy Officer | 100.2K | – | Jul 29, 2026 | Form 4 |
| Karl S. DahlquistChief Legal Officer | 87.3K | – | Aug 24, 2026 | Form 4 |
| Vinayak DoraiswamyChief Scientific Officer | 86.5K | – | Jul 28, 2026 | Form 4 |
| B Kristine JohnsonDirector | 53.5K | – | Nov 6, 2026 | Form 4 |
| Sven WehrweinDirector | 40.5K | – | Jul 28, 2026 | Form 4 |
| Regina E GrovesDirector | 34.5K | – | Sep 11, 2026 | Form 4 |
| Karen PrangeDirector | 22.8K | – | Aug 5, 2026 | Form 4 |
| Maggie YuenDirector | 14.0K | – | Aug 5, 2026 | Form 4 |
A lower bound: it counts only the 11 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.22%
- IHIiShares U.S. Medical Devices ETFWeight in the fund0.22%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.08%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.08%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.05%
- IWMiShares Russell 2000 ETFWeight in the fund0.04%
- VBKVanguard Small-Cap Growth Index FundWeight in the fund0.04%
- VHTVanguard Health Care Index FundWeight in the fund0.03%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.03%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
20 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 224
- Q4 2025: Managers 234
- Q1 2026: Managers 227
- Q2 2026: Managers 252
Institutional investors by quarter
The fund managers holding ATRC, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 252 managers held 52.87M shares, worth $1.5B. During the quarter 52 opened a position, 27 closed one, 99 added and 60 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+11%
- Wellington Management GroupIn the quarter+3.3%
- Vanguard Portfolio ManagementIn the quarter+16%
- Hood River Capital ManagementIn the quarter-6.8%
- AlliancebernsteinIn the quarter-15%
- Vanguard Capital ManagementIn the quarter+1.6%
- Nomura Asset Management InternationalIn the quarter-3.9%
- Goldman Sachs GroupIn the quarter-4.1%
- State StreetIn the quarter+6.7%
- Marshall WaceIn the quarter-9.1%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 4.47M | +11% | $125M |
| Wellington Management Group | 3.50M | +3.3% | $98M |
| Vanguard Portfolio Management | 3.13M | +16% | $87M |
| Hood River Capital Management | 2.91M | -6.8% | $81M |
| Alliancebernstein | 2.77M | -15% | $79M |
| Vanguard Capital Management | 2.19M | +1.6% | $61M |
| Nomura Asset Management International | 1.73M | -3.9% | $49M |
| Goldman Sachs Group | 1.60M | -4.1% | $45M |
| State Street | 1.39M | +6.7% | $39M |
| Marshall Wace | 1.33M | -9.1% | $37M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do AtriCure's filings show?
Who buys and sells is one part of AtriCure's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ATRC's insiders bought or sold?
From Jul 2, 2026 to Nov 10, 2026 AtriCure's insiders bought 0 and sold $4.0M of shares on the market. 36% of the sales were under set 10b5-1 plans.
Which well-known managers hold ATRC?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $32M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.